Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model

NCT01479374 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

397

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: AL-4943A ophthalmic solution
DRUG: AL-4943A vehicle
DRUG: Olopatadine hydrochloride ophthalmic solution, 0.2%

Sponsor

Alcon Research